Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Cyborg Bionic Syst ; 2021: 9851834, 2021.
Article in English | MEDLINE | ID: mdl-36285136

ABSTRACT

Origami, a traditional Japanese art, is an example of superior handwork produced by human hands. Achieving such extreme dexterity is one of the goals of robotic technology. In the work described in this paper, we developed a new general-purpose robot system with sufficient capabilities for performing Origami. We decomposed the complex folding motions into simple primitives and generated the overall motion as a combination of these primitives. Also, to measure the paper deformation in real-time, we built an estimator using a physical simulator and a depth camera. As a result, our experimental system achieved consecutive valley folds and a squash fold.

2.
Intern Med ; 53(18): 2061-5, 2014.
Article in English | MEDLINE | ID: mdl-25224188

ABSTRACT

An adolescent girl presented with inappetence. Upper gastrointestinal endoscopy showed rough and cracked mucosa at the gastric antrum with a scarred duodenal ulcer, and a biopsy sample demonstrated abundant eosinophils. We therefore diagnosed the patient as having eosinophilic gastroenteritis. Eradication therapy for Helicobacter pylori (H. pylori) did not improve her symptoms; however, proton pump inhibitor therapy was effective in resolving her chief complaints. There are several reports of eosinophilic gastroenteritis complicated with H. pylori infection in which the association between eradication therapy and the patient's symptoms is unclear. In the present case, the patient's symptoms did not improve with eradication therapy, and there appeared to be no relationship between the two.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Enteritis/complications , Eosinophilia/complications , Gastritis/complications , Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Pyloric Antrum/microbiology , Adolescent , Diagnosis, Differential , Endoscopy, Gastrointestinal , Enteritis/diagnosis , Eosinophilia/diagnosis , Female , Gastritis/diagnosis , Helicobacter Infections/complications , Helicobacter Infections/drug therapy , Humans , Pyloric Antrum/pathology
3.
Histopathology ; 64(4): 536-46, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24117499

ABSTRACT

AIMS: Gastric gland mucin contains O-glycans exhibiting terminal α1,4-linked N-acetylglucosamine residues (αGlcNAc). Recently we demonstrated that mice deficient in αGlcNAc in gastric gland mucin develop gastric adenocarcinoma spontaneously, indicating that αGlcNAc is a tumour suppressor for gastric cancer. However, the role of αGlcNAc in Barrett's oesophagus (BO) remains unknown. In this study, we investigated whether reduced αGlcNAc expression in BO is associated with development of Barrett's adenocarcinoma (BAC). METHODS AND RESULTS: Thirty-five BO lesions adjacent to BAC were examined by immunohistochemistry for αGlcNAc, MUC6 and CDX2. As controls, 35 BO lesions without BAC obtained from patients with oesophageal squamous cell carcinoma were also analysed. Expression of αGlcNAc relative to its scaffold MUC6 in BO adjacent to BAC was reduced significantly compared to control BO. Decreased αGlcNAc expression in BO adjacent to BAC was particularly significant in patients with smaller tumour size (<20 mm) and minimal invasion of tumour cells to the superficial muscularis mucosae. There was also a significant inverse correlation between αGlcNAc and CDX2 expression in BO adjacent to BAC. CONCLUSIONS: Decreased expression of αGlcNAc compared with MUC6 in BO is a possible hallmark in predicting BAC development.


Subject(s)
Acetylglucosamine/metabolism , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Barrett Esophagus/metabolism , Barrett Esophagus/pathology , Esophageal Neoplasms/metabolism , Esophageal Neoplasms/pathology , Aged , Aged, 80 and over , Animals , Biomarkers, Tumor/metabolism , CDX2 Transcription Factor , Case-Control Studies , Disease Progression , Female , Homeodomain Proteins/metabolism , Humans , Immunohistochemistry , Male , Mice , Middle Aged , Mucin-6/metabolism , Polysaccharides/metabolism
4.
Clin J Gastroenterol ; 6(1): 38-45, 2013 Feb.
Article in English | MEDLINE | ID: mdl-26181403

ABSTRACT

A 46-year-old man underwent gastrointestinal endoscopy while visiting the hospital for a general physical check-up. Coarse mucosa in the antrum with superficial erosions was found by endoscopic gastrointestinal examination, but no atrophic changes were seen in the corpus. Histopathological examination of gastric biopsy specimens revealed mucosa-associated lymphoid tissue (MALT) lymphoma. Although Helicobacter pylori was not detected in our patient, H. heilmannii was identified histologically and by polymerase chain reaction analysis, resulting in the diagnosis of H. heilmannii-associated gastric MALT lymphoma. We successfully eradicated H. heilmannii and achieved complete remission of gastric MALT lymphoma by antibiotic therapy. H. heilmannii usually causes milder gastritis than H. pylori, but it has been more closely associated with MALT lymphoma. As such, when H. pylori infection is excluded in patients with gastric MALT lymphoma, physicians should next consider the possibility of H. heilmannii. Furthermore, our research suggests that eradication therapy is effective for treatment of localized H. heilmannii-associated gastric MALT lymphoma.

5.
Case Rep Gastroenterol ; 6(2): 319-27, 2012 May.
Article in English | MEDLINE | ID: mdl-22754493

ABSTRACT

Rectal mucosa-associated lymphoid tissue (MALT) lymphoma is a rare condition. Although the majority of patients undergo surgical resection, a definitive treatment for rectal MALT lymphoma has not yet been established. In the present study, we report the outcome of radiotherapy in 3 patients with rectal MALT lymphoma. Our cohort ranged from 56 to 65 years of age. The male/female ratio was 1:2, and all patients were in stage I (Lugano classification) of the disease. Endoscopic findings revealed elevated lesions resembling submucosal tumors in 2 patients, and a sessile elevated lesion with a nodular surface in 1 patient. One of the 3 patients underwent magnifying endoscopy with crystal violet staining that demonstrated a type I pit pattern (Kudo's classification) lesion with a broad intervening area caused by the upthrust of the tumor from the submucosa. All patients tolerated radiotherapy at doses of 30 Gy without major complications and achieved complete remission. Follow-up ranged from 13 to 75 months (mean 51.0 months), revealing no recurrence of MALT lymphoma. As such, we propose radiotherapy to be a safe and effective means for treating rectal MALT lymphoma.

6.
J Clin Invest ; 122(3): 923-34, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22307328

ABSTRACT

Gastric gland mucin secreted from the lower portion of the gastric mucosa contains unique O-linked oligosaccharides (O-glycans) having terminal α1,4-linked N-acetylglucosamine residues (αGlcNAc). Previously, we identified human α1,4-N-acetylglucosaminyltransferase (α4GnT), which is responsible for the O-glycan biosynthesis and characterized αGlcNAc function in suppressing Helicobacter pylori in vitro. In the present study, we engineered A4gnt(-/-) mice to better understand its role in vivo. A4gnt(-/-) mice showed complete lack of αGlcNAc expression in gastric gland mucin. Surprisingly, all the mutant mice developed gastric adenocarcinoma through a hyperplasia-dysplasia-carcinoma sequence in the absence of H. pylori infection. Microarray and quantitative RT-PCR analysis revealed upregulation of genes encoding inflammatory chemokine ligands, proinflammatory cytokines, and growth factors, such as Ccl2, Il-11, and Hgf in the gastric mucosa of A4gnt(-/-) mice. Further supporting an important role for this O-glycan in cancer progression, we also observed significantly reduced αGlcNAc in human gastric adenocarcinoma and adenoma. Our results demonstrate that the absence of αGlcNAc triggers gastric tumorigenesis through inflammation-associated pathways in vivo. Thus, αGlcNAc-terminated gastric mucin plays dual roles in preventing gastric cancer by inhibiting H. pylori infection and also suppressing tumor-promoting inflammation.


Subject(s)
Gastric Mucins/metabolism , Stomach Neoplasms/metabolism , Adenocarcinoma/metabolism , Adenoma/metabolism , Aged , Aged, 80 and over , Animals , Cell Proliferation , Disease Progression , Helicobacter pylori/metabolism , Humans , Inflammation , Mice , Mice, Transgenic , Middle Aged , Models, Biological , N-Acetylglucosaminyltransferases/metabolism , Neovascularization, Pathologic , Oligonucleotide Array Sequence Analysis
7.
Clin J Gastroenterol ; 5(1): 20-3, 2012 Feb.
Article in English | MEDLINE | ID: mdl-26181870

ABSTRACT

A 52-year-old man was admitted to our hospital complaining of abdominal pain. A blood test showed high serum levels of biliary enzymes and amylase. Surprisingly, a computed tomography scan revealed complete separation of the ventral and dorsal pancreas and swelling of the ventral pancreas with choledocholithiasis. Surgical cholecystectomy was performed to remove the bile duct stones after endoscopic removal was unsuccessful. The complete separation of the pancreatic parenchyma caused by ventral pancreas malrotation seen in this case is extremely rare, and may provide important information regarding embryologic development, deformity, and malfunction of the pancreas.

8.
J Gastroenterol ; 46(12): 1353-60, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21853260

ABSTRACT

BACKGROUND: Recently, a significant relationship between gastric cancer and Helicobacter pylori infection has been proven. The purpose of this study was to elucidate the actual conditions of H. pylori infection in Japanese teenagers. METHODS: The study subjects were students at a certain high school between 2007 and 2009. They were first examined with a urinary rapid test kit based on immunochromatographic technology [corrected] for detection of the antibody to H. pylori (RAPIRAN®). [corrected]. Students who tested positive on this screening examination visited Shinshu University Hospital and received esophagogastroduodenoscopy, and biopsy samples were taken to examine their H. pylori status. The resolution of H. pylori infection was assessed by urea breath test. RESULTS: For 3 years, 1,224 of 1,232 students (99.4%) received a screening examination for H. pylori infection. Sixty-four of these 1,224 students (5.2%) were found to be positive for H. pylori. Thirty of these 64 H. pylori-positive students visited our hospital, and 24 of them (80%) were confirmed to be infected by H. pylori. The most common endoscopic findings for students with H. pylori infection were nodular gastritis (58.3%) and closed-type atrophic gastritis (45.8%). Histological findings showed no evidence of intestinal metaplasia, except in one of the students. All 24 students were successfully cured of H. pylori infection. If this procedure were to be introduced into the nationwide health screening at Japanese high schools, we calculated that the cost of the prevention of a gastric cancer would be 454,073 yen for each person. CONCLUSIONS: The low rate of prevalence of H. pylori infection in Japanese teenagers would make it possible to perform examinations and carry out treatment for this infection in high school health screenings from the standpoint of medical economy.


Subject(s)
Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Mass Screening/methods , Adolescent , Biopsy , Breath Tests/methods , Endoscopy, Digestive System , Enzyme-Linked Immunosorbent Assay , Female , Helicobacter Infections/complications , Helicobacter Infections/drug therapy , Humans , Japan , Male , Stomach Neoplasms/microbiology , Stomach Neoplasms/prevention & control , Students , Urea/metabolism
9.
Intern Med ; 46(20): 1745-8, 2007.
Article in English | MEDLINE | ID: mdl-17938532

ABSTRACT

A case of esophageal cancer who suffered from tracheal stenosis at the tracheostomy after stent implantation is presented. The patient received a covered metallic tracheal stent to seal the esophago-respiratory fistulation. After six months, the tracheal retainer for his tracheostomy was difficult to insert into his trachea due to the growth of the cancer. Argon plasma coagulation (APC) has been successfully employed in the dilatation of tracheal stenosis at the tracheostomy. We herein describe the use of APC as an effective treatment for further palliative therapy of tracheal dilatation in order to treat tracheal stenosis by esophageal cancer after stent implantation.


Subject(s)
Airway Obstruction/therapy , Esophageal Neoplasms/complications , Esophagoscopy , Stents , Tracheal Stenosis/therapy , Tracheoesophageal Fistula/therapy , Airway Obstruction/etiology , Bronchoscopy , Dilatation , Humans , Male , Middle Aged , Neoplasm Invasiveness , Palliative Care , Trachea/pathology , Tracheal Stenosis/etiology , Tracheoesophageal Fistula/etiology
10.
Hepatology ; 45(2): 384-90, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17256726

ABSTRACT

UNLABELLED: Genetic predisposition to type 1 autoimmune hepatitis (AIH) is linked mainly to HLA class II genes. We previously searched the whole HLA region for AIH susceptibility genes using microsatellite markers and found only HLA-DR/DQ to be a candidate region for this suspected multifactorial disease. As such, the aim of this study was to broaden our search and screen the whole genome for additional genes that might contribute to type 1 AIH susceptibility. Eighty-one patients with type 1 AIH (15 men, 66 women, average age 55.9) and 80 healthy sex- and age-matched Japanese controls were enrolled in this study. We performed a case-control association study using 400 polymorphic microsatellite markers with an average spacing of 10.8 cM distributed throughout the whole genome. Two markers, one on chromosome 11 (D11S902, Pc = 0.013) and one on chromosome 18 (D18S464, Pc = 0.008), were revealed to have statistically significant associations with AIH. An additional 7 markers (D2S367, D6S309, D9S273, D11S1320, D16S423, D17S938, and D18S68) were also found to be candidate susceptibility regions. In addition, our results showed there were 17 regions that may contain genes of resistance to AIH. No specific markers were detected in HLA-DR4-negative patients, and no differences were seen in the clinical courses of patients (severe versus mild to moderate). CONCLUSION: This first genomewide scan of Japanese AIH patients revealed at least 26 candidate AIH susceptibility or resistance regions other than HLA class II loci. These results also suggested that the products of several genes interact to determine heritable susceptibility to AIH.


Subject(s)
DNA/genetics , Genome, Human/genetics , Hepatitis, Autoimmune/genetics , Microsatellite Repeats/genetics , Asian People/genetics , Case-Control Studies , Chromosomes, Human, Pair 11 , Chromosomes, Human, Pair 18 , Female , Gene Frequency/genetics , Genetic Predisposition to Disease/ethnology , Hepatitis, Autoimmune/ethnology , Humans , Japan/ethnology , Male , Middle Aged , Polymorphism, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...